COVID Update: Pfizer CEO to Seek Approval to US, UK Regulators as Vaccine Trial Results Shows 95% Effectiveness Pfizer CEO Albert Bourla said on November 18 that he would seek approval from U.S. and U.K. for market release by early December as the company's coronavirus vaccine candidate found to be 95% effective. by CJ Robles